Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Orthopaedics and Related Research®
Published in: Clinical Orthopaedics and Related Research® 9/2017

01-09-2017 | CORR Insights

CORR Insights®: Free Vascularized Fibular Grafting Improves Vascularity Compared With Core Decompression in Femoral Head Osteonecrosis: A Randomized Clinical Trial

Author: Anton Plakseychuk, MD, PhD

Published in: Clinical Orthopaedics and Related Research® | Issue 9/2017

Login to get access

Excerpt

For many years, core decompression was generally considered a mainstay of treatment for avascular necrosis (AVN) of the femoral head [4, 5]. But more than 20 years ago, multiple studies [7, 17] demonstrated that this procedure has a limited success rate and is probably best used in patients with small, early AVN lesions. At the same time, free vascularized fibula graft, a complex and labor intensive procedure that requires microsurgical anastamosis of the vessels [18, 19], saw wider use. Because of the complexity of free vascularized fibula graft surgery, and in order to perform it efficiently, the procedure is often done using two teams of surgeons working simultaneously, an impractical proposition for community hospitals. For that reason, most of them continue to perform core decompression today [14, 16]. …
Literature
1.
Calori GM, Mazza E, Colombo A, Mazzola S, Colombo M. Core decompression and biotechnologies in the treatment of avascular necrosis of the femoral head. EFORT Open Rev. 2017;2:41–50.CrossRefPubMedPubMedCentral
2.
Cui Y, Kaisaierjiang A, Cao P, Wu ZY, Lv Q. Association of apolipoprotein A5 genetic polymorphisms with steroid-induced osteonecrosis of femoral head in a Chinese Han population. Diagn Pathol. 2014;9:229.CrossRefPubMedPubMedCentral
3.
Fang T, Zhang EW, Sailes FC, McGuire RA, Lineaweaver WC, Zhang F. Vascularized fibular grafts in patients with avascular necrosis of femoral head: A systematic review and meta-analysis. Arch Orthop Trauma Surg. 2013;133:1–10.CrossRefPubMed
4.
Ficat RP. Idiopathic bone necrosi of the femoral head. Early diagnosis and treatment. J Bone Joint Surg Br. 1985;67:3–9.PubMed
5.
Hungerford DS. Response: The role of core decompression in the treatment of ischemic necrosis of the femoral head. Arthritis Rheum. 1989;32:801–806.CrossRefPubMed
6.
Kim SY, Kim YG, Kim PT, Ihn JC, Cho BC, Koo KH. Vascularized compared with nonvascularized fibular grafts for large osteonecrotic lesions of the femoral head. J Bone Joint Surg Am. 2005;87:2012–2018.CrossRefPubMed
7.
Koo KH, Kim R, Ko GH, Song HR, Jeong ST, Cho SH. Preventing collapse in early osteonecrosis of the femoral head: A randomized clinical trial of core decompression. J Bone Joint Surg Br. 1995;77:870–874.PubMed
8.
Lau RL, Perruccio AV, Evans HM, Mahomed SR, Mahomed NN, Gandhi R. Stem cell therapy for the treatment of early stage avascular necrosis of the femoral head: A systematic review. BMC Musculoskelet Disord. 2014;15:156.CrossRefPubMedPubMedCentral
9.
Lieberman JR, Conduah A, Urist MR. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res. 2004;429:139–145.CrossRef
10.
Liu B, Cao Y, Wang D, Yao G, Bi Z. Vascular endothelial growth factor -634G/C polymorphism associated with osteonecrosis of the femoral head in a Chinese population. Genet Test Mol Biomarkers. 2012;16:739–743.CrossRefPubMed
11.
Mao Q, Wang W, Xu T, Zhang S, Xiao L, Chen D, Jin H, Tong P. Combination treatment of biomechanical support and targeted intra-arterial infusion of peripheral blood stem cells mobilized by granulocyte-colony stimulating factor for the osteonecrosis of the femoral head: A randomized controlled clinical trial. J Bone Miner Res. 2015;30:647–656.CrossRefPubMedPubMedCentral
12.
Papakostidis C, Tosounidis TH, Jones E, Giannoudis PV. The role of “cell therapy” in osteonecrosis of the femoral head. Acta Orthop. 2016;87:72–78.CrossRefPubMed
13.
Plakseychuk AY, Kim SY, Park BC, Varitimidis SE, Rubash HE, Sotereanos DG. Vascularized compared with nonvascularized fibular grafting for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Am. 2003;85:589–596.CrossRefPubMed
14.
Sadile F, Bernasconi A, Russo S, Maffulli N. Core decompression versus other joint preserving treatments for osteonecrosis of the femoral head: A meta-analysis. Br Med Bull. 2016;118:33–49.CrossRefPubMedPubMedCentral
15.
Sen RK, Tripathy SK, Aggarwal S, Marwaha N, Sharma RR, Khandelwal N. Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: A randomized control study. J Arthroplasty. 2012;27:679–686.CrossRefPubMed
16.
Shah SN, Kapoor CS, Jhaveri MR, Golwala PP, Patel S. Analysis of outcome of avascular necrosis of femoral head treated by core decompression and bone grafting. J Clin Orthop Trauma. 2015;6:160–166.CrossRefPubMedPubMedCentral
17.
Smith SW, Fehring TK, Griffin WL, Beaver WB. Core decompression of the osteonecrotic femoral head. J Bone Joint Surg Am. 1995;77:674–680.CrossRefPubMed
18.
Sotereanos DG, Plakseychuk AY, Rubash HE. Free vascularized fibula grafting for the treatment of osteonecrosis of the femoral head. Clin Orthop Relat Res. 1997;344:243–256.CrossRef
19.
Urbaniak JR, Coogan PG, Gunneson EB, Nunley JA. Treatment of osteonecrosis of the femoral head with free vascularized fibular grafting. A long-term follow-up study of one hundred and three hips. J Bone Joint Surg Am. 1995;77A:681–694.CrossRef
20.
Wang XY, Niu XH, Chen WH, Lin N, Song JN, Chen B, Jin H. Effects of apolipoprotein A1 and B gene polymorphism on avascular necrosis of the femoral head in Chinese population. Zhongguo Gu Shang. 2008;21:99–102.PubMed
21.
Xiong MY, Li-Qiang L, Shi-Qiong L, Zhen-Hui L, Hang-Fei G. Effects of osteoprotegerin, RANK and RANKL on bone destruction and collapse in avascular necrosis femoral head. Am J Transl Res. 2016;8:3133–3140.PubMedPubMedCentral
22.
Zhao D, Cui D, Wang B, Tian F, Guo L, Yang L, Liu B, Yu X. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50:325–330.CrossRefPubMed
Metadata
Title
CORR Insights®: Free Vascularized Fibular Grafting Improves Vascularity Compared With Core Decompression in Femoral Head Osteonecrosis: A Randomized Clinical Trial
Author
Anton Plakseychuk, MD, PhD
Publication date
01-09-2017
Publisher
Springer US
Published in
Clinical Orthopaedics and Related Research® / Issue 9/2017
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-017-5425-3

Other articles of this Issue 9/2017

Clinical Orthopaedics and Related Research® 9/2017 Go to the issue

Clinical Research

Periprosthetic Joint Infection Is the Main Cause of Failure for Modern Knee Arthroplasty: An Analysis of 11,134 Knees

Basic Research

Combined Administration of ASCs and BMP-12 Promotes an M2 Macrophage Phenotype and Enhances Tendon Healing

Clinical Research

Can a Three-Component Prosthesis be Used for Conversion of Painful Ankle Arthrodesis to Total Ankle Replacement?

Editor's Spotlight/Take 5

Editor’s Spotlight/Take 5: Do Surgeon Expectations Predict Clinically Important Improvements in WOMAC Scores After THA and TKA?

CORR Insights

CORR Insights®: Periprosthetic Joint Infection Is the Main Cause of Failure for Modern Knee Arthroplasty: An Analysis of 11,134 Knees

Clinical Research

Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?